Novo Nordisk sues Eli Lilly over ads claiming Zepbound yields 50-pound weight loss versus Wegovy's 33 pounds, alleging deceptive comparisons using peak doses against outdated lower doses. Lilly defends based on trial results.
Novo Nordisk Sues Eli Lilly Over Weight-Loss Ads
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →